Literature DB >> 23112899

Comparative Study of Two Silicone Hydrogel Contact Lenses used as Bandage Contact Lenses after Photorefractive Keratectomy.

Hasan Razmjoo1, Elham Abdi, Sayna Atashkadi, Akhlaghi M Reza, Peyman A Reza, Mojtaba Akbari.   

Abstract

BACKGROUND: Silicon hydrogel bandage contact lenses are used to enhance epithelial healing, control surface-generated pain, and prevent epithelial erosions after refractive surgery. Considering the importance of faster reepithelialization in preventing complications of photorefractive keratectomy (PRK) and the fact that the features and specifications of these commercially-available lenses are different and their performance as a postoperative bandage lenses would be different also, the aim of this study was comparison the efficacy of senofilcon A and lotrafilcon A after PRK.
METHODS: In this prospective study, 44 patients with PRK in both eyes randomly received a silicon hydrogel contact lens of senofilcon A in one eye and lotrafilcon A in other eye. Then the epithelial defect size, visual acuity and subjective level of pain and discomfort were measured for both eyes and compared on day 1, 3 and 5 postoperatively.
RESULTS: There was no statistical difference in rate of reepithelialization between senofilcon A and lotrafilcon A (P > 0.05). The mean pain and discomfort index was significantly lower in eyes with senofilcon A (P < 0.05). The mean subjective visual scores were similar with both bandage contact lenses (BCLs) (P > 0.05).
CONCLUSION: Silicon hydrogel BCLs are safe and effective for corneal reepithelialization and have great therapeutic outcome on visual outcomes after PRK. But, senofilcon A had better effect on postoperative pain and discomfort which made it superior than lotrafilcon A. However for more conclusive results, it is recommended to study larger sample size with evaluation the possible factors responsible for the obtained findings regarding postoperative pain and discomfort.

Entities:  

Keywords:  Bandage contact lens; photorefractive keratectomy; silicon hydrogel contact lens

Year:  2012        PMID: 23112899      PMCID: PMC3483000     

Source DB:  PubMed          Journal:  Int J Prev Med        ISSN: 2008-7802


INTRODUCTION

Refractive surgery is used for refractive error correction. Excimer laser corrects myopia, hyperopia, and astigmatism by ablating the anterior corneal surface. Photorefractive keratectomy (PRK), a well-established flapless refractive procedure, is one of the major refractive surgical techniques, which has been introduced since more than 20 years.[12] Though the use of this technique has been decreased by introduction of laser in situ keratomileusis (LAISIK) procedure, due to its higher postoperative pain and more delayed visual recovery, but it could be an alternative to LAISIK in cases with thin corneas, and epithelial basement membrane disease (often called map-dot-fingerprint-dystrophy), and irregular corneas, and treatment of some LASIK flap complications. With the advent of wave front guided laser ablation the popularity of PRK is increasing. In addition, this technique decreases postoperative higher order optical aberrations and improves quality of vision.[34] Though the therapeutic utilities of soft contact lenses have been introduced since 40 years ago, but their use became more important recently, after introduction of refractive surgery. They are used as a bandage after PRK. First, they were used to decrease postoperative pain but nowadays they used for promoting reepithelialization after PRK.[5-8] Using hydrogel lenses for bandage purpose after corneal refractive procedures was applied first in photorefractive keratectomy (PRK).[79] Silicon hydrogel bandage lenses are used to protect the cornea during healing and provide pain relief.[79] Silicon hydrogel bandage contact lenses (BCLs) widely reported to offer improved ocular health and are 5-6 times more O2-permeable than traditional hydrogel soft lenses. Their mechanism is to prevent epithelial erosion, enhance epithelial healing, and to control surface generated pain.[10] They are used as extended wear basis, and they should have high oxygen permeability for providing corneal metabolism.[11] Silicon hydrogel bandage contact lenses are made of high oxygen permeability materials; this gas permeability related to the size of the intermolecular voids that allow the transmission of oxygen molecules and the gas solubility of the silicone material.[12] Different types of silicone hydrogel lenses are available and several methods are used to manufacture them. Two of the most popular of these BCLs are senofilcon A and lotrafilcon A. They have the food and drug administration (FDA) approval for using as BCL after PRK.[13] Considering the importance of faster reepithelialization in preventing complications of PRK and the fact that the features and specifications of these commercially-available lenses are different and their performance as a postoperative bandage lenses would be different also, the aim of this study was comparison the efficacy of senofilcon A and lotrafilcon A after PRK.

METHODS

In this double-masked study, patients who had bilateral low myopia (-6.00D) and anisometropia less than 2.00 D and referred to Faize hospital, affiliated to Isfahan University of Medical Sciences, for binocular PRK surgery, from July to December 2011 were enrolled. The Medical Ethics Committee of the Isfahan University of Medical Sciences approved the study protocol (Research project number; 390384). Written informed consent was obtained from all participants. Patients with a history of contact lens wear during 1 month before PRK, previous refractive surgery and any condition that delays epithelial healing were excluded. The surgical procedure was performed by one surgeon (HR). The corneal epithelium was removed by application of 20% absolute alcohol for 20-45 seconds to the corneal surface to loosen the epithelium and separate it with a hockey knife then laser ablation was performed with the technolas 217z100 excimer laser. At the end of procedure, patients were randomly selected to be fitted with senofilcon A bandage contact lens in one eye and lotrafilcon A in the fellow eye by the surgeon who performed the procedure. Specifications of two studied lens, senofilcon A and lotrafilcon A are presented in Table 1.
Table 1

Specifications of two studied lens, senofilcon A and lotrafilcon A

Specifications of two studied lens, senofilcon A and lotrafilcon A Postoperative medication included a combination of topical ciprofloxacin eye drops four times per day and topical betamethasone eye drops eight times per day and acetaminophen codeine for pain control. Objective and subjective assessments 1, 3 and 5 days postoperatively were performed by two ophthalmologists unaware of the type of bandage contact lens in each eye. Objective assessments included epithelial defect size, visual acuity and subjective assessment was evaluating the patientspain, tearing, photophobia and discomfort using questionnaire. Pain and discomfort evaluated by using a rating scale of 0 to 4 as follows: 0 Z no discomfort or pain; 1 Z mild discomfort; 2 Z moderate burning pain; 3 Z burning pain requiring oral medication (acetaminophen codeine 325/10); 4 Z severe constant or sharp pain not relieved with narcotic pain medications.

Statistical Analysis

Obtained data was analyzed using SPSS version 18 software and chi-square and independent sample t-test. P value < 0.05 were considered as significant.

RESULTS

In this study, 44 patients (16 men and 28 women) were studied. Mean age of studied population was 27.18 ± 3.9 years. Postoperative details regarding epithelial defect size, visual acuity and subjective level of pain and discomfort in A and lotrafilcon A 1, 3 and 5 days after operation, are presented in Table 2.
Table 2

Postoperative details regarding epithelial defect size, visual acuity and subjective level of pain and discomfort in senofilcon A and lotrafilcon A 1, 3 and 5 days after operation

Postoperative details regarding epithelial defect size, visual acuity and subjective level of pain and discomfort in senofilcon A and lotrafilcon A 1, 3 and 5 days after operation Both, two group patients had worse ucva on third day than the first day. On day five, V/A improved and 97.7% of patients reached at least on ucva of 20/40 [Figure 1].
Figure 1

Mean logMAR visual acuity in two studied lens on 1, 3 and 5 days postoperatively (P> 0.05)

Mean logMAR visual acuity in two studied lens on 1, 3 and 5 days postoperatively (P> 0.05) Thirty six eyes had completely reepithelialized by the fifth day; 21 (58.3%) eyes with senofilcon A and 15 (41.7%) eyes with lotrafilcon A (P > 0.05).

DISCUSSION

In this study, the outcome and efficacy of two commonly used Silicon hydrogel bandage contact lenses (BCLs) was compared. The results indicated that regarding objective variables there were not significant differences between two studied BCLs. But pain and discomfort indexes, the subjective variables, were significantly lower in eyes with senofilcon A. As mentioned, PRK is one of the methods of choice for refractive error correction. In this technique, te corneal epithelium should be removed and sculpting of the deepithelialized corneal surface will change its refractive power.[14] Faster reepithelialization facilitates earlier visual rehabilitation, reduction of discomfort and quicker restoration of barrier. BCLs are used to prevent corneal traumatic damage and promote reepithelialization and reduce discomfort after PRK. BCLs are fitted on deepithelialized corneas and are used on an extended wear basis, therefore, they should have high oxygen permeability. In silicon hydrogel BCLs, silicon material with bulky molecular structure creates an open polymer architecture and great O2 permeability.[15] Many studies have confirmed the therapeutic effects of silicone hydrogel lenses as bandage contact lenses after corneal refractive surgery, since their introduction in 1998.[16-19] The general procedure of PRK surgery requires the patient to wear a bandage contact lens for three to five days after surgery on an extended wear schedule to promote epithelial healing. The only contact lenses FDA approved for extended and continuous wear are silicone hydrogels. Currently there are three silicone hydrogel contact lenses that are FDA approved for therapeutic use as a BCL: Lotrafilcon A, Balafilcon A, and Senofilcon A.[13] The therapeutic efficacy of the lotrafilcon A BCL after PRK has been reported in some previous studies.[151920] Accordingly, it results in reducing discomfort and faster corneal reepithelialization after the procedure. Therefore, in this study we compared the efficacy and therapeutic outcome of lotrafilconA with another silicone hydrogel BCL, senofilcon A, from different manufacturer and with different characteristics (such as O2 permeability, O2 transmissibility, diameter and water content)(Table 1) and with same base curve (8.40 mm) after PRK. Both of the selected BCLS have FDA approval. In order to reduce the effect of environmental conditions and patient's individual healing response and achieving more accurate results, all patients were randomly fitted with these lenses and they were masked to which type of BCL was in which eye. Some similar studies have investigated the efficacy of different BCLs in this regard, but there was not any study which compared senofilcon A with lotrafilcon A. However, mentioned studies compare the outcome of other BCLS with lotrafilcon A. The findings of this study indicated that the rate of reepithelialization and the mean subjective visual scores of two studied BCLs were not significantly different but the mean pain and discomfort index was significantly lower in eyes with senofilcon A. The therapeutic efficacy of the lotrafilcon A BCL after PRK has been reported in some previous studies. In a similar study in the USA, Engle and colleagues have compared the efficacy of 2 types of BCLs, etafilcon A and lotrafilcon A, after PRK. They showed that lotrafilcon A is more effective. It was more effective in reducing patient discomfort and faster corneal reepithelialization, especially during the first 48 h after PRK.[15] Grentzelos et al., in Greece have compared the outcome of two BCLs, lotrafilcon A and lotrafilcon B after PRK and reported similar results for both studied BCLs.[19] Edwards and colleagues in the USA, have evaluated the efficacy of two BCLs with high and low oxygen permeability, lotrafilcon A and omafilcon A, on visual outcomes after PRK. Their results indicated that rate of reepithelialization, uncorrected visual acuity, contrast sensitivity and goal of emmetropia were similar in two BCLs.[20] Our results indicated that regarding pain and discomfort senofilcon A had superior effect than lotrafilcon A. It may be due to the difference in stiffness of lens materials. Considering the specifications of studied lenses, the water content of senofilcon A was higher than lotrafilcon A. Regarding to patients' related factors, Grentzelos et al. indicated that higher grade of pain and discomfort due to sensory nerve exposure is associated with larger epithelial defects. Similar to this study, Engle et al. did not report such a correlation, but Grentzelos reported the mentioned association. It seems that other factors as a part of pain sensation may have role, which should be investigated in future studies.[19] In current study, both two group patients had worse ucva on third day than the first day. On day 5, V/A improved and 97.7% of patients reached at least on ucva of 20/40. A similar result reported by Grentzelos et al.[19] It may be due to that, at that time the epithelial healing process is in the center of the cornea. The findings of the current study are in line with our previous trial for relieving pain after keratectomy.[21]

CONCLUSION

In general our findings indicated that, as reported by previous studies, silicon hydrogel BCLs are safe and effective for corneal reepithelialization and have great therapeutic outcome on visual outcomes after PRK. But, senofilcon A had better effect on postoperative pain and discomfort, which made it superior than lotrafilcon A. However, for more conclusive results, it is recommended to study larger sample size with evaluation the possible factors responsible for the obtained findings regarding postoperative pain and discomfort.
  18 in total

Review 1.  Laser eye surgery for refractive errors.

Authors:  Tohru Sakimoto; Mark I Rosenblatt; Dimitri T Azar
Journal:  Lancet       Date:  2006-04-29       Impact factor: 79.321

Review 2.  Overview of laser refractive surgery.

Authors:  Samuel Chao-ming Huang; Hung-Chi Jesse Chen
Journal:  Chang Gung Med J       Date:  2008 May-Jun

3.  Therapeutic contact lenses.

Authors:  H L Gould
Journal:  Int Ophthalmol Clin       Date:  1970

4.  Photorefractive keratectomy for low-to-moderate myopia and astigmatism with a small-beam, tracker-directed excimer laser.

Authors:  M B McDonald; M R Deitz; J M Frantz; M C Kraff; R R Krueger; J J Salz; C R Kraff; E Maguen; C S Matta; A B Nesburn; L W Piebenga
Journal:  Ophthalmology       Date:  1999-08       Impact factor: 12.079

5.  Seven-day extended wear and 30-day continuous wear of high oxygen transmissibility soft silicone hydrogel contact lenses: a randomized 1-year study of 504 patients.

Authors:  S E Nilsson
Journal:  CLAO J       Date:  2001-07

6.  Adaptive effects of 30-night wear of hyper-O(2) transmissible contact lenses on bacterial binding and corneal epithelium: a 1-year clinical trial.

Authors:  David H Ren; Kazuaki Yamamoto; Patrick M Ladage; Michael Molai; Ling Li; W Matthew Petroll; James V Jester; H Dwight Cavanagh
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

7.  Efficacy of 2 types of silicone hydrogel bandage contact lenses after photorefractive keratectomy.

Authors:  Michael A Grentzelos; Sotiris Plainis; Nikolaos I Astyrakakis; Vasilios F Diakonis; George D Kymionis; Panagiotis Kallinikos; Ioannis G Pallikaris
Journal:  J Cataract Refract Surg       Date:  2009-12       Impact factor: 3.351

8.  Retrospective case series of therapeutic applications of lotrafilcon a silicone hydrogel soft contact lenses.

Authors:  Jésus Montero; Jane Sparholt; René Mély; Bill Long
Journal:  Eye Contact Lens       Date:  2003-04       Impact factor: 2.018

9.  Effects of lotrafilcon A and omafilcon A bandage contact lenses on visual outcomes after photorefractive keratectomy.

Authors:  Jayson D Edwards; Kraig S Bower; Denise A Sediq; Jenna M Burka; Richard D Stutzman; Cameron R Vanroekel; Chrystyna P Kuzmowych; Jennifer B Eaddy
Journal:  J Cataract Refract Surg       Date:  2008-08       Impact factor: 3.351

10.  Preoperative Topical Diclofenac and Ketorolac in Prevention of Pain and Discomfort Following Photorefractive Keratectomy: A Randomized Double-masked Placebo-controlled Clinical Trial.

Authors:  Hassan Razmju; Ahmadreza Khalilian; Alireza Peyman; Seyed-Hossein Abtahi; Mohammad-Ali Abtahi; Mojtaba Akbari; Leyli Sadri
Journal:  Int J Prev Med       Date:  2012-03
View more
  5 in total

1.  Comparative evaluation of Comfilcon A and Senofilcon A bandage contact lenses after transepithelial photorefractive keratectomy.

Authors:  Achyut Mukherjee; Antonis Ioannides; Ioannis Aslanides
Journal:  J Optom       Date:  2014-06-13

2.  Comparison of Samfilcon A and Lotrafilcon B silicone hydrogel bandage contact lenses in reducing postoperative pain and accelerating re-epithelialization after photorefractive keratectomy.

Authors:  Erdem Yuksel; Kemal Ozulken; Mehmet Murat Uzel; Ayse Guzin Taslipinar Uzel; Semih Aydoğan
Journal:  Int Ophthalmol       Date:  2019-05-07       Impact factor: 2.031

Review 3.  Corneal Regeneration After Photorefractive Keratectomy: A Review.

Authors:  Javier Tomás-Juan; Ane Murueta-Goyena Larrañaga; Ludger Hanneken
Journal:  J Optom       Date:  2014-10-23

4.  Comparison of efficacy of two different silicone hydrogel bandage contact lenses after T-PRK.

Authors:  Hua Li; Ting Shao; Jia-Fan Zhang; Lin Leng; Sai Liu; Ke-Li Long
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

5.  Evaluation of the safety and efficacy of therapeutic bandage contact lenses on post-cataract surgery patients.

Authors:  Dan-Na Shi; Hang Song; Tong Ding; Wei-Qiang Qiu; Wei Wang
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.